Haemodynamic effects of the nitroxyl donor cimlanod ( BMS ‐986231) in chronic heart failure: a randomized trial-Reference-Cited by-同舟云学术

Haemodynamic effects of the nitroxyl donor cimlanod ( BMS ‐986231) in chronic heart failure: a randomized trial

Published:2021-03-09 Issue:7 Volume:23 Page:1147-1155
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Lang Ninian N.¹,Ahmad Faheem A.¹,Cleland John G.²³,O'Connor Christopher M.⁴,Teerlink John R.⁵,Voors Adriaan A.⁶,Taubel Jorg⁷,Hodes Anke R.⁶,Anwar Mohamed⁸,Karra Ravi⁹,Sakata Yasushi¹⁰,Ishihara Shiro¹¹,Senior Roxy¹²,Khemka Abhishek¹³,Prasad Narayana G.¹⁴,DeSouza Mary M.¹⁵,Seiffert Dietmar¹⁵,Ye June Y.¹⁵,Kessler Paul D.¹⁵,Borentain Maria¹⁵,Solomon Scott D.¹⁴,Felker G. Michael¹⁶,McMurray John J.V.¹

Affiliation:

1. BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular & Medical Sciences, University of Glasgow Glasgow UK

2. Robertson Centre for Biostatistics & Clinical Trials University of Glasgow Glasgow UK

3. National Heart & Lung Institute Royal Brompton & Harefield Hospitals, Imperial College London UK

4. Inova Heart & Vascular Institute Falls Church VA USA

5. Department of Cardiology San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco San Francisco CA USA

6. Department of Cardiology University of Groningen, University Medical Centre Groningen Groningen The Netherlands

7. Richmond Pharmacology Limited London UK

8. Centre for Cardiovascular Science University of Edinburgh Edinburgh UK

9. Department of Medicine Duke Advanced Heart and Lung Failure Clinic, Duke University School of Medicine Durham NC USA

10. Department of Cardiovascular Medicine Osaka University Hospital Suita Osaka Japan

11. Department of Cardiology Nippon Medical School Kawasaki‐shi Japan

12. Department of Cardiovascular Research Northwick Park Hospital & Department of Cardiology, Royal Brompton Hospital London UK

13. Department of Cardiology Indiana University School of Medicine Indianapolis IN USA

14. Cardiovascular Division Brigham and Women's Hospital Boston MA USA

15. Bristol‐Myers Squibb Princeton NJ USA

16. Division of Cardiology Duke Clinical Research Institute (DCRI), Duke University School of Medicine Durham NC USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2138

Reference21 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. 2013 ACCF/AHA Guideline for the Management of Heart Failure

3. Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart FailureA Randomized Controlled Trial

4. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials

5. The pharmacology of nitroxyl (HNO) and its therapeutic potential: Not just the janus face of NO11This review is dedicated to the career of Prof. Herbert T. Nagasawa, a pioneer in the field of HNO chemistry, biochemistry and pharmacology.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rhodamine-based fluorescent probe used to determine nitroxyl (HNO) in lysosomes;Analytical Biochemistry;2024-09

2. Developing Photoactive Coumarin-Caged N-Hydroxysulfonamides for Generation of Nitroxyl (HNO);Molecules;2024-08-19

3. The chemistry of HNO-releasing compounds;Redox Biochemistry and Chemistry;2024-06

4. Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231);European Journal of Heart Failure;2023-12-28

5. New cimlanod trial provides insights into mechanistic effects of vasodilators in heart failure;European Journal of Heart Failure;2023-12-28